Product Details
Nat-Lanthanum
Lanthanum250 mg
Chewable Tablet
DIN/PIN/NPN
02498731
Manufacturer
Natco Pharma (Canada) Inc.
Formulary Listing Date
2020-08-28
Unit Price
1.2034
Amount MOH Pays
1.2034
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
V03AE03
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02498731 | Nat-Lanthanum | 1.2034 | 1.2034 |
02287145 | Fosrenol | NA | NA |
LU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Chronic Renal Failure Drugs – Telephone Request Service (TRS) Drugs | Lanthanum
Sevelamer Hydrochloride
Sevelamer Carbonate
Updated: June 7, 2021
Notes:
Exclusion Criteria: Sevelamer will not be reimbursed in the following cases:
Duration of approval: lifetime On a case-by-case basis, requests may be considered for sevelamer under the EAP for a patient with serum phosphate less than 1.8mmol/L and calcium values less than 2.65 mmol/L. |